ImageneBio, Inc. (IMA) stock
IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.81−0.09 (-2.31%)
Close on Nov 18, 2026Market cap $43.25MP/E –Yield –
ImageneBio net income
Net income is the profit left for shareholders after every expense, interest and tax.
ImageneBio's net income for the twelve months ending Jun 30, 2026 was -$52.48M. For fiscal 2025 it was -$45.35M. The highest annual figure on record is -$34.12M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$45.35M | – |
| FY2024 | Dec 31, 2024 | -$36.57M | – |
| FY2023 | Dec 31, 2023 | -$68.17M | – |
| FY2022 | Dec 31, 2022 | -$68.77M | – |
| FY2021 | Dec 31, 2021 | -$34.12M | – |
| FY2020 | Dec 31, 2020 | -$44.26M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$10.62M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.91M | – |
| Q3 FY2025 | Sep 30, 2025 | -$24.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.59M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.08M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.26M | – |
| Q1 FY2024 | Mar 31, 2024 | -$22.31M | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.49M | – |
| Q3 FY2023 | Sep 30, 2023 | -$17.34M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.10M | -604.0% |
| Q3 FY2022 | Sep 30, 2022 | -$17.34M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.49M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.84M | – |
| Q4 FY2021 | Dec 31, 2021 | $2.80M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.52M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.68M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.72M | – |
| Q4 FY2020 | Dec 31, 2020 | -$26.05M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.04M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.95M | – |
See a number that looks wrong?